Why Care Should Be Longitudinal
It All Begins Here
The damage that stays: why quitting alcohol does not always erase the past
By: Dr. Pranav Oza, MD, PhDFrom the Desk of Dr. Oza: This article was originally published on my personal Substack, where I write about the intersection of rigorous medical science, public health advocacy, and long-term primary care. To get updates on clinical insights and systemic health strategies delivered directly to your inbox, you can read and subscribe to the full publication here.
A patient I saw recently has been on my mind. I will call him Mike.
Mike quit drinking more than ten years ago. He stopped after a terrible gout attack that left him barely able to walk. It was his third flare in two years, and by then his body was making the message hard to ignore.
To his credit, he changed his life. He joined a support group. He started exercising. He replaced his nightly beer with sparkling water and lime. He stayed sober.
So, when we sat down to review his labs at his annual physical, I could see the disappointment on his face.
“But doc, I quit. I have been good for eleven years.”
And he had been.
But his body was still carrying some of the effects of those earlier years. His blood pressure was high. His cholesterol had crept up. His uric acid was still elevated. An ultrasound showed fatty liver disease.
That is the part many people do not realize.
Stopping alcohol is worth it. It lowers risk. It allows healing. It can change the course of someone’s life.
But it does not always mean the body goes back to a clean slate.
Years of heavy drinking can leave a biological footprint. It can affect the liver, blood pressure, metabolism, uric acid, the heart, and even the brain. Some damage improves and some risk decreases over time. But some changes need to be watched and managed long after the drinking has stopped.
Mike’s gout, in hindsight, was not just gout.
It was a warning signal.
Alcohol, especially beer, can drive up uric acid and trigger gout attacks. But elevated uric acid is not just about painful joints. It is also linked with kidney disease, cardiovascular risk, and metabolic problems.
For Mike, the gout was the loud symptom. The blood pressure, fatty liver, and cholesterol were the quieter ones.
When I explained this to him, he was quiet for a while.
Then he asked the question I hear often:
“Was quitting even worth it?”
YES! Absolutely.
Quitting was one of the best decisions he could have made. It likely prevented things from getting much worse. It gave his body a chance to recover. It improved his quality of life.
But quitting does not mean he no longer needs follow-up.
That is where the partnership with his doctor matters.
My role is not to make him feel punished for his past. My role is to help him understand what his body is telling us now, and to make a plan with him. We can treat the blood pressure. We can manage the cholesterol. We can monitor the liver. We can follow the uric acid. We can help keep him healthy and reduce the chance that old damage turns into bigger problems later.
He still needs his doctors to know his alcohol history, even though it is years behind him. Not because it defines him, but because it helps us take better care of him.
That is really the point of this post.
If you are drinking heavily now, do not wait for your body to force the decision. The sooner you stop, the less damage there is to carry forward.
If you have already stopped, do not skip your checkups. Be honest with your doctor about your past drinking, even if it feels irrelevant now. It is not. Your doctor can help you build a plan to stay well.
And if you are young and thinking, “I will deal with it later,” please know that later comes faster than most people expect.
Mike is doing well now. He is still sober. He is taking care of his health. And we are watching the things that need to be watched. That ongoing partnership is part of what will keep him going strong.
He wanted his story shared because he knows it may help someone else take action sooner.
The body can heal a great deal. But it also remembers.
If you found this article helpful, consider subscribing to Dr. Oza's newsletter exploring preventive medicine, chronic disease management, public health, and the physician-patient relationship.
References:
1. Udo, Vásquez Shaw (2015) N = 25,840 U.S. adults ≥30 years old; compared individuals in full AUD remission >5 years vs. those with no AUD history.
After adjusting for current drinking, smoking, BMI, psychiatric comorbidities, and sociodemographics, a lifetime history of AUD remained independently associated with increased risk for:
Hypertension (OR 1.12)
Diabetes (OR 1.23)
Myocardial infarction (OR 1.35)
Liver disease (OR 1.24)
Arthritis (OR 1.06)
Elderly individuals (≥65 years) were most affected — AUD history was associated with significantly more total chronic conditions (1.93 vs. 1.73, p .01), even after full adjustment
Women with past AUD had independently elevated risk for myocardial infarction (OR 1.45) and liver disease (OR 1.71)
Longer AUD exposure (>5 years) doubled the risk of myocardial infarction (OR 2.05) and nearly doubled arteriosclerosis risk (OR 1.79)
2. Kendler et al., 2016 Swedish cohort, N = 2.8 million, (1973–2010):
AUD was associated with an overall mortality HR of 5.83
Even after accounting for familial/genetic confounding, AUD independently increased mortality risk
3. Jung et al. (2022) 372 AUD cases vs. 243 healthy controls; replicated in Generation Scotland (N = 4,219).
AUD causes measurable, dose-dependent acceleration of biological aging through epigenetic mechanisms. These changes (telomere shortening, immune dysregulation, and hippocampal volume loss) may persist after cessation and contribute to the residual morbidity observed in remitted AUD patients.
4. Kamsvaag et al. (2026) Norwegian registry study, N = 2,736 adults ≥60 years assessed for cognitive impairment (NorCog registry, 2014–2018).
This study examined whether AUD diagnoses (ICD-10 codes F10, G31.2, G62.1, K70, T51.0) were associated with healthcare costs among older adults being evaluated for cognitive symptoms.